Ernst, Simon https://orcid.org/0000-0002-4794-213X
Dirschka, Thomas
Article History
Received: 17 April 2026
Accepted: 5 June 2026
First Online: 25 June 2026
Declarations
:
: Simon Ernst has no conflicts of interest to declare. Thomas Dirschka has received research support, lecture honoraria, and consulting fees from Abbvie, Aesclepion, Almirall, Beiersdorf, Biofrontera, Damae, Dr. August Wolff, Dr. Pfleger, Emblation, Galderma, GSK, Infectopharm, Intros, ISDIN, Janssen-Cilag, La Roche Posay, Leo, L ‘Óreal, Louis Widmer, Mylan, Neracare, Nordberg, Novartis, Olistic, Pfizer, Pierre Fabre, Riemser, Schulze and BöhmGmbH, Scibase S.A., Smartinmedia AG, Speclipse, UCB, Vichy.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.